Slide 1: ESG Update 2024: Sustainability as Business and Impact Driver
///////////// Health for all, Hunger for none ESG UPDATE 2024 Sustainability as Business and Impact Driver B a y e r A G / / / E S G U p d a t e / / / J u n e 1 9 th, 2 0 2 4
Slide 2: Cautionary Statements Regarding Forward-Looking Information
. Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the
Slide 3: Agenda
Agenda Key-note speech 1 Regenerative Agriculture 2 Access to Self Care 3 Global Health Unit 4 Daniella Foster Dr. Claus Runge Bill Anderson Frank Terhorst Head of Public Affairs, Market Head of Public Affairs, Chief Executive Officer & Chief Head of Strategy & Sustainability, Access & Sustainabilit
Slide 4: Keynote speech: Bill Anderson
Keynote speech Bill Anderson /////////// Chief Executive Officer & Chief Sustainability Officer
Slide 5: Real impact towards an important mission
Real impact towards an important mission OUR AREAS of IMPACT ( Full-Year 2023) OUR MISSION and VISIONS //////////// 20% Climate Scope 1 & 2 emissions reduction Action Health for All, Hunger for None. vs. 2019 Produce 50% More. 46 mil Women in LMIC 53 mil Restore Nature. Scale Regenerative Ag. with m
Slide 6: Regenerative Agriculture
Regenerative Agriculture Frank Terhorst /////////// Head of Strategy & Sustainability, Crop Science
Slide 7: Our vision of regenerative agriculture
Our vision of regenerative agriculture Our Vision aspires to address global challenges at scale Produce 50% More. Restore Nature. Scale Regenerative Ag. Required increase by To meet our 2030 sustainability To expand our footprint to reach our 2050 to feed the world commitments 400M acre ambition by
Slide 8: Outcome-driven, multi-season, system approach
Outcome-driven, multi-season, system approach Bayer products support system solution approach to deliver Regenerative agriculture outcomes IMPROVED SOIL PRODUCTIVITY HEALTH SEEDS CROP PROTECTION & TRAITS FARMER SOCIAL- CLIMATE ECONOMIC MITIGATION & WELL-BEING ADAPTATION DIGITAL SERVICES SOLUTIONS BI
Slide 9: Our business potential
Our business potential Agriculture input market growing over two percent to meet demand Potential to double our accessible market through investments in innovation in adjacent spaces >100bn¹ >100bn¹EUR EUR >200bn1 EUR 2023 2023Global GlobalAgAgInput Market Input Market 2030 Global Ag Input Market &
Slide 10: CS portfolio and innovation support Regenerative Ag outcomes and unlock new market potential
CS portfolio and innovation support Regenerative Ag outcomes and unlock new Market potential Business examples showcase contribution to Regenerative Ag and growth potential >100bn¹ Core business enablesEUR Regen Ag outcomes Investments in innovation in adjacent spaces enable CS and sustainability co
Slide 11: Access to Self-care
Access to Self-care Daniella Foster /////////// Head of Public Affairs, Market Access & Sustainability, Consumer Health
Slide 12: Reimagining our vision to serve billions of people
Reimagining our vision to serve Billions of people Meeting consumers’ everyday health needs with science-based solutions, while accelerating business growth at scale 50% of the world Overstretched Climate Change without access to health systems biggest health threat basic health services Challenges
Slide 13: Meeting the needs of underserved consumers
Meeting the needs of underserved consumers We focus on the priority everyday health needs in underserved communities, as expressed by consumers and informed by medical insights, to transform self-care solutions, consumer empowerment and ecosystems PORTFOLIO ADAPTATION Designed to meet underserved co
Slide 14: Bridging the Nutrient Gap for generations – India example
Bridging the Nutrient Gap for generations – India example Bayer signature initiative to enable access to essential vitamins and minerals for 50M people in underserved communities annually by 2030 as One Bayer FOOD ///// //// SUPPLEMENTS Solutions to grow fruits, Essential vegetables, grains, supplem
Slide 15: Saving Hearts and Lives with Aspirin
Saving Hearts and Lives with Aspirin People in underserved communities and on the front line of climate change (heat, pollution) have much higher cardiac risks, while they cannot afford heavy treatments Lowering the barriers to entry to diagnose heart risks and access life-saving and affordable hear
Slide 16: What's coming next: Charting the path to Health Equity for All
What’s coming next: Charting the path to Health Equity for All Leveraging our agile capabilities and mobilizing external partners Serving the Mobilizing underserved ecosystem with DSO for Billions Radical focus Accelerating on underserved tech for health consumer needs Focused Mobilizing the portfol
Slide 17: Global Health Unit
Global Health Unit Dr. Claus Runge /////////// Head of Public Affairs, Sustainability & Internal Engagement, Pharmaceuticals
Slide 18: Our Vision translates into Sustainable Impact Generation
Our Vision translates into Sustainable Impact Generation Treat the Untreatable. Cure Diseases. Offer Hope. Advance Tackle Health Gender Equity Inequalities Eliminate NTDs 100m AtMI Kigali women Top 10 Declaration Sustainability with access to modern contraception in Tiered pricing and Patient Afford
Slide 19: Progress on Access to Contraception
Progress on Access Europe/ to Contraception Middle East/Africa ~29 million women reached Latin America in 2023 ~8 million women reached in 2023 Asia/Pacific ~9 million women reached in 2023 Target 2030: Fulfill the need of 100 million women in LMICs for modern contraception1 44 46 We support individ
Slide 20: Progress on Access to NCDs & NTDs Rx – more can be done
Progress on Access to NCDs & NTDs Rx – Registrations of Kerendia in LMICs, more can be done 31 26 for Nubeqa 5.7 Patients reached through PAPs in m ‘21-’23, fueling growth in LMICs Emodepside R&D Patients reached (Phase Patients through III) through reached HAT closeinto‘21-’23, PAPs eliminationfuel
Slide 21: Introducing the Global Health Unit (GHU)
Introducing the Global Health Unit (GHU) A Social Business Model for > 50 Underserved Markets Worldwide Fostering Inclusive Growth GHU Scope: Deliver against all Strong, but not exclusive focus on divisional ESG Commitments, LMICs with no Bayer PH presence including the 100m challenge (n=56 underser
Slide 22: GHU in Action
GHU in Action Expanding patient reach Ambitions going forward 5 African Double digit Capacity 500 k Countries m€ Value Building Women 22 /// Bayer /// ESG Investor Update Webinar /// June 2024
Slide 23: Introduction as new Head of ESG
Introduction as new Head of ESG Dr. Chitkala Kalidas /////////// Head of Environment, Social & Governance (ESG)
Slide 24: Our new Global Head of ESG: Dr. Chitkala Kalidas
Our new Global Head of ESG: Dr. Chitkala Kalidas Introduction Professional background Education: scientist by training; PhD in Microbiology from Cornell University Experience: ~25 years at the intersection of life sciences and business incl. management consulting, R&D portfolio management, global dr
Slide 25: Climate Transition Plan
Climate Transition Plan Matthias Berninger /////////// Head of Public Affairs, Sustainability & Safety
Slide 26: Bayer Climate Strategy
Bayer Climate Strategy Navigating the Path to Net Zero and Transformation to new Value Pools I. Transition toward Net Zero II. Transformation to New Value Pools Aligned with the Paris Agreement and SBTi approved1 Health for all . Hunger for none Reduction: Reduce our GHG emissions by at least 90% by
Slide 27: Transition towards Net Zero
Transition towards Net Zero Legend: Scope 1. 2 & 3 Emissions in mtCO2-e Permanent long-term removals in mtCO2-e 13.8 12.2 Climate Contributions & Nature-based solutions in mtCO2-e 9.9 Mt -90% CO2e 2019 Base 2023 Achievement 2024 Shot-Term target 2029 near-term targets* 2050 long-term target* Own emi
Slide 28: Transform to New Value Pools
Transform to New Value Pools Transform Agriculture with Climate Crisis is a Health Crisis Innovation & Regenerative Agriculture Heart Reproductive Adaption Health health / CROP PROTECTION SEEDS & TRAITS Women DIGITAL SOLUTIONS SERVICES Clear Nutrition Mitigation Breathing Hunger for none 1GT CO2e Gl
Slide 29: Questions & Answers
Questions & Answers 29 /// Bayer /// ESG Investor Update Webinar /// June 2024